{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:57Z","timestamp":1787010057871,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/jcp.0b013e3182367aee","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T04:09:11Z","timestamp":1319170151000},"page":"763-768","source":"Crossref","is-referenced-by-count":58,"title":["A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder"],"prefix":"10.1097","volume":"31","author":[{"given":"Juliana Belo","family":"Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseli Gedanke","family":"Shavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Fossaluza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorrin","family":"Koran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto de Bragan\u00e7a","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euripedes Constantino","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00406-004-0459-4","article-title":"Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course.","volume":"254","author":"Angst","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00406-004-0544-8","article-title":"Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.","volume":"255","author":"Rufer","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0022-3859.40773","article-title":"Family burden, quality of life and disability in obsessive compulsive disorder: an Indian perspective.","volume":"54","author":"Gururaj","year":"2008","journal-title":"J Postgrad Med"},{"issue":"27","key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1192\/S0007125000293355","article-title":"The social costs of anxiety disorders.","author":"Leon","year":"1995","journal-title":"Br J Psychiatry Suppl"},{"issue":"3","key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0193-953X(05)70177-5","article-title":"Quality of life in obsessive-compulsive disorder.","volume":"23","author":"Koran","year":"2000","journal-title":"Psychiatr Clin North Am"},{"issue":"6","key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mppsy.2007.04.001","article-title":"Pharmacological treatment for obsessive-compulsive disorder.","volume":"6","author":"Fineberg","year":"2007","journal-title":"Psychiatry"},{"issue":"3","key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14656560903446948","article-title":"Treatment strategies for obsessive-compulsive disorder.","volume":"11","author":"Marazziti","year":"2010","journal-title":"Exp Opin Pharmacother"},{"issue":"8","key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.cpr.2008.07.001","article-title":"Psychological treatment of obsessive-compulsive disorder: a meta-analysis.","volume":"28","author":"Rosa-Alcazar","year":"2008","journal-title":"Clin Psychol Rev"},{"issue":"10","key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1517\/14656566.5.10.2059","article-title":"Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder.","volume":"5","author":"Walsh","year":"2004","journal-title":"Exp Opin Pharmacother"},{"issue":"4","key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-first revision.","volume":"9","author":"Bandelow","year":"2008","journal-title":"World J Biol Psychiatry"},{"issue":"7","key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","article-title":"A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.","volume":"11","author":"Bloch","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"6","key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4088\/JCP.08m04369","article-title":"A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.","volume":"70","author":"Matsunaga","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R14-14-20210128","first-page":"CD006625","article-title":"Quetiapine versus other atypical antipsychotics for schizophrenia.","author":"Komossa","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-244X-5-5","article-title":"Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study ISRCTN83050762.","volume":"5","author":"Carey","year":"2005","journal-title":"BMC Psychiatry"},{"issue":"8","key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4088\/JCP.v65n0803","article-title":"A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.","volume":"65","author":"Denys","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004850-200507000-00005","article-title":"Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study.","volume":"20","author":"Fineberg","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4088\/JCP.08m04269","article-title":"Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients.","volume":"70","author":"Vulink","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/JCP.0b013e318185e735","article-title":"Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.","volume":"28","author":"Kordon","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.yic.0000215083.57801.11","article-title":"Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials.","volume":"21","author":"Fineberg","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/JCP.0b013e3181dbfb53","article-title":"Long-term follow-up study of patients with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder.","volume":"30","author":"Reddy","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1176\/jnp.2008.20.4.450","article-title":"Long-term follow-up study of patients with refractory obsessive-compulsive disorder.","volume":"20","author":"Ross","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0269881108099423","article-title":"Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.","volume":"24","author":"Diniz","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"5","key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","article-title":"Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an 11CDASB positron emission tomography study.","volume":"161","author":"Meyer","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"7","key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","article-title":"Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.","volume":"30","author":"Spina","year":"2008","journal-title":"Clin Ther"},{"issue":"3","key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2125.1992.tb04134.x","article-title":"The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.","volume":"34","author":"Crewe","year":"1992","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopsych.2006.12.014","article-title":"Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors?","volume":"61","author":"Denys","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"11","key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"R30-14-20210128","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-Brown Obsessive Compulsive Scale. II. Validity.","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"0","key":"R32-14-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000395074","article-title":"Assessment of depression: the depression inventory.","volume":"7","author":"Beck","year":"1974","journal-title":"Mod Probl Pharmacopsychiatry"},{"issue":"6","key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"9","key":"R34-14-20210128","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archpsyc.1976.01770090101010","article-title":"Assessment of social adjustment by patient self-report.","volume":"33","author":"Weissman","year":"1976","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"1","key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1176\/ajp.155.1.102","article-title":"The Brown Assessment of Beliefs Scale: reliability and validity.","volume":"155","author":"Eisen","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"6","key":"R39-14-20210128","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1590\/S1807-59322009000600005","article-title":"Sequential allocation to balance prognostic factors in a psychiatric clinical trial.","volume":"64","author":"Fossaluza","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"R40-14-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/bimj.200310045","article-title":"Parametric and nonparametric analyses of repeated ordinal categorical data.","volume":"46","author":"Singer","year":"2004","journal-title":"Biometr J"},{"issue":"2","key":"R41-14-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0924-9338(99)80725-1","article-title":"Citalopram for treatment-resistant obsessive-compulsive disorder.","volume":"14","author":"Pallanti","year":"1999","journal-title":"Eur Psychiatry"},{"issue":"4","key":"R42-14-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674379303800402","article-title":"The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.","volume":"38","author":"Browne","year":"1993","journal-title":"Can J Psychiatry"},{"issue":"11","key":"R43-14-20210128","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1017\/S1092852900014024","article-title":"Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients.","volume":"13","author":"Marazziti","year":"2008","journal-title":"CNS Spectr"},{"issue":"1","key":"R44-14-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/cap.1998.8.61","article-title":"Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.","volume":"8","author":"Figueroa","year":"1998","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"R45-14-20210128","first-page":"677","article-title":"Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD).","volume":"32","author":"Ravizza","year":"1996","journal-title":"Psychopharmacol Bull"},{"issue":"4","key":"R46-14-20210128","first-page":"171","article-title":"Fluoxetine-clomipramine interaction.","volume":"56","author":"Sternbach","year":"1995","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R47-14-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1520-6394(1997)5:2<84::AID-DA4>3.0.CO;2-5","article-title":"Clomipramine augmentation in treatment-resistant depression.","volume":"5","author":"Amsterdam","year":"1997","journal-title":"Depress Anxiety"},{"issue":"2","key":"R49-14-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(00)00133-4","article-title":"D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.","volume":"11","author":"Gefvert","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"R50-14-20210128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1192\/bjp.163.6.833","article-title":"Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.","volume":"163","author":"Busatto","year":"1993","journal-title":"Br J Psychiatry"},{"issue":"1","key":"R51-14-20210128","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s002130000643","article-title":"Dose relationship of limbic-cortical D2-dopamine receptor occupancy with risperidone.","volume":"154","author":"Yasuno","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"R52-14-20210128","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder.","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"5","key":"R53-14-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(98)00114-0","article-title":"Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.","volume":"44","author":"Blier","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"6","key":"R54-14-20210128","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004850-199711000-00003","article-title":"A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.","volume":"12","author":"Rasmussen","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"R55-14-20210128","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1176\/appi.ajp.159.1.88","article-title":"Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.","volume":"159","author":"Koran","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"10","key":"R56-14-20210128","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/da.20740","article-title":"Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.","volume":"27","author":"Liebowitz","year":"2010","journal-title":"Depress Anxiety"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201112000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:17:17Z","timestamp":1618021037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201112000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182367aee","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}